Portfolio comparison
Merck Sharp and Dohme LLC vs Transkaryotic Therapies Inc
Side-by-side portfolio analysis — patents indexed, year ranges, and activity timeline.
Company A
Merck Sharp and Dohme LLC
Patents indexed
1
Year range
2018
Most recent
2018
biotechpharmaceutical
Top Patents1 enriched
US 10028963· 2018
How to Treat Severe Lung Infections Using Ceftolozane and Tazobactam
Activity by Decade
2010s1
Company B
Transkaryotic Therapies Inc
Patents indexed
1
Year range
2003
Most recent
2003
biotechpharmaceutical
Top Patents1 enriched
US 6531124· 2003
How to Use Modified Cells to Produce Insulin-Regulating Proteins in the Body
Activity by Decade
2000s1
How to use
Bookmark a comparison URL to save it. Format: /compare/companies?a=[slug]&b=[slug]. Also see patent-level comparison.